The COVID-19 pandemic should serve as a wake up call.
Pharmaceutical companies are interested in appearing concerned about drug affordability, but their efforts are always superficial and short-lived.
It’s hard to even look at my medical bills.
At what point are drug companies choosing to harm people in favor of making a profit?
I had to start stockpiling my insulin.
No one should ever have to wonder if they can afford to stay alive.
Real people like me are struggling.
I want pharmaceutical companies to remember the people who are using and paying for their medications.
As patients, we have the power.
It is time for pharmaceutical companies to make drugs affordable rather than spending frivolously or hoarding money for the executives.
Statement on Gilead’s Remdesivir Price
Today’s news proves that Gilead aims to profiteer off the COVID-19 pandemic.
DATA SET: Drug Companies Keep Raising Prices in the Midst of a Pandemic
The first case of COVID-19 in the United States was reported on January 20. According to our analysis, pharmaceutical corporations hiked the prices of 245 drugs between January 20 and June 20.
NEW REPORT: Big Pharma Hikes Drug Prices in Midst of COVID-19 Crisis
Drug companies raised the price of nearly 250 drugs since COVID-19 arrived in U.S.; 75 percent of those were drugs linked to COVID-19.
